Galena Biopharma In The News
- Galena Biopharma to Present at the 27th Annual ROTH Conference
- Galena Biopharma to Report Fourth Quarter and Year End 2014 Financial Results on Thursday, March 5, 2015
- Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
- Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets in the U.S.
Galena is committed to ensuring eligible patients have access to our products. Learn more at GalenaPatientServices.com.